Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFor weight loss, the best time of day to take semaglutide depends on which form you are using. The weekly injection can be taken on any day at any time of day that suits your routine, while the daily tablet must be taken first thing in the morning on an empty stomach, at least 30 minutes before food, drink or other medicines. Neither version requires a specific clock time, but consistency matters more than the hour you choose. Like all prescription-only medicines in this class, semaglutide for weight loss is only available following a clinical assessment by a qualified prescriber, who will advise on the schedule that fits your circumstances.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The short answer is no — at least not in the way many people assume. Wegovy (semaglutide 2.4 mg) is a once-weekly subcutaneous injection with a half-life of around one week, meaning the medicine accumulates steadily in your system rather than peaking and troughing with each dose. Because the level in your bloodstream stays relatively stable across seven days, there is no pharmacological reason to inject at a particular hour. Morning and evening injections have not been shown to produce different weight outcomes in clinical trials.
What does matter is picking a day and a rough time slot and sticking with it. The reason is practical: your next injection should be roughly seven days after the last one (though the prescribing guidance allows a window of one to two days either side if you miss your usual day, check the Patient Information Leaflet or speak to your prescriber). Some people choose Monday morning because it slots neatly around a weekly routine. Others prefer a Sunday evening when there is no rush. The right time for Wegovy is genuinely whichever time you will reliably remember.
One practical note: if nausea is a concern in the early weeks of treatment, some people find injecting in the evening means any queasiness fades overnight, and our guide to semaglutide time of day explores that and other timing considerations in more depth. That is not an instruction, it is an observation worth discussing with your prescriber. The semaglutide overview on the NHS medicines pages covers the general side-effect profile in detail.
Yes, considerably more. The Wegovy tablet (oral semaglutide, approved by the MHRA on 11 June 2026 as the first oral GLP-1 medicine licensed for weight management in the UK) works very differently from the injection. Its active ingredient is the same molecule, but it is co-formulated with an absorption enhancer called SNAC that only works reliably under very specific conditions: an empty stomach, a small amount of plain water, no food, no coffee, no other oral medicines for at least 30 minutes afterwards.
That is why the morning is essentially the only workable time for most people. You need a window before eating or drinking anything other than water, and that window is easiest to protect first thing. The sequence is simple: wake, take the tablet with up to about 120 ml of plain water, wait at least 30 minutes, then carry on with breakfast and the rest of the morning. If the tablet is taken with food or a hot drink, absorption can fall significantly and the medicine may not reach effective levels.
For people already established on the weekly 2.4 mg injection, the MHRA's approval information notes that moving to the 25 mg maintenance tablet is subject to clinical assessment rather than a straightforward swap. Your prescriber leads that conversation. If you want to understand the broader practical guidance on taking semaglutide correctly, that page covers the injection technique, rotation sites and storage alongside the tablet rules.
Life happens, and occasionally the day you chose in week one does not work by week eight. Changing your usual injection day is generally acceptable, provided at least two days (48 hours) separate consecutive injections. After that, the new day becomes your regular schedule going forward. Do not double up to compensate for a missed dose. These rules come from the semaglutide Patient Information Leaflet and your prescriber, not from general guidance, always confirm the specifics with whoever is managing your treatment.
Timing questions come up regularly among people transferring from one provider to another. If you are considering that, where Wegovy is sourced matters as much as when you take it: the safety record of a medicine depends partly on whether it came through the licensed UK supply chain. The MHRA has warned publicly about counterfeit weight-loss pens sold online, some of which have been found to contain entirely different substances. A pharmacy you can verify on the GPhC register is the baseline check worth doing before any online purchase.
Not in terms of the clock, but dose increases do bring a reset of sorts. Many people find that the nausea or digestive discomfort they had largely settled by week four or five returns briefly after a step up. Some choose to time a dose increase for a quieter period (a long weekend, a week with fewer commitments) so that any short-term discomfort is easier to manage. That is not a clinical instruction; it is the kind of pragmatic thinking that our prescribers tend to discuss with patients at review.
The STEP 1 trial, published in the New England Journal of Medicine, showed around 15% average weight reduction over 68 weeks at the 2.4 mg maintenance dose alongside lifestyle changes, and that result was built on consistent weekly dosing rather than any specific time of day. Consistency is the variable that actually moves outcomes. A dose taken reliably at 9 pm on Thursdays outperforms one injected erratically at the theoretically optimal moment.
If you are still weighing up the injection against the tablet, the Wegovy treatment overview sets out both formats and how they compare in terms of licensing, trial evidence and practical use. Separately, if you are at the stage of comparing treatment options more broadly, the weight-loss treatment overview covers where semaglutide sits alongside other licensed choices. And if cost context is relevant to your decision, our treatment information page sets out what is included in a private prescription through a regulated pharmacy, without hidden fees.
Semaglutide is a prescription-only medicine. A prescriber assesses every patient individually before treatment begins, and that assessment is repeated at each repeat order. If you are ready to take that step, start your free consultation and a GPhC-registered independent prescriber will review your details the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.